Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gender Differences in SREC Use and Nicotine Dependence
NCT03856515Phase 1Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jun 2022
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised trial of nicotine in nicotine dependence (2 arms), sponsored by University of Texas MD Anderson Cancer Center. Primary endpoint: Cigarettes Per Day at 2 weeks. Started Jun 2022; status: completed.
02
Drugs
nicotine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT03856515.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03856515.